4//SEC Filing
LILLY ENDOWMENT INC 4
Accession 0000316011-25-000093
CIK 0000059478other
Filed
Nov 25, 7:00 PM ET
Accepted
Nov 26, 4:00 PM ET
Size
9.1 KB
Accession
0000316011-25-000093
Insider Transaction Report
Form 4
LILLY ENDOWMENT INC
10% Owner
Transactions
- Sale
Common Stock
2025-11-25$1108.71/sh−5,043$5,591,225→ 92,207,567 total - Sale
Common Stock
2025-11-25$1109.45/sh−9,249$10,261,294→ 92,198,318 total - Sale
Common Stock
2025-11-25$1110.53/sh−1,340$1,488,106→ 92,196,978 total
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,108.07 to $1,109.06, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1), (2), and (3) to this Form 4.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,109.08 to $1,110.07, inclusive.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,110.20 to $1,110.96, inclusive.
Documents
Issuer
ELI LILLY & Co
CIK 0000059478
Entity typeother
IncorporatedIN
Related Parties
1- filerCIK 0000316011
Filing Metadata
- Form type
- 4
- Filed
- Nov 25, 7:00 PM ET
- Accepted
- Nov 26, 4:00 PM ET
- Size
- 9.1 KB